The Evaluation of SATB2 as a Diagnostic Immunohistochemical Marker of Colorectal Adenocarcinoma in Comparison with Non-Colorectal Adenocarcinomas. (2023). Journal of Pharmaceutical Negative Results, 2280-2289. https://doi.org/10.47750/pnr.2023.14.02.278